How Generative Vision Language AI is Transforming Radiology with Louis Blankemeier Cognita
Release Date: 05/13/2026
How Generative Vision Language AI is Transforming Radiology with Louis Blankemeier Cognita TRANSCRIPT
Empowered Patient Podcast
Louis Blankemeier, CEO and Co-Founder of Cognita, describes the significant gap between the number of radiologists and the rising volume and types of medical imaging that need to be reviewed. The Cognita generative visual language model is an advancement over earlier radiology AI applications that were designed to flag single findings. This integrated approach emulates a radiologist by analyzing complex images and generating full draft radiology reports, demonstrating reduced time per case, increased detection of critical findings, and decreased cognitive burden on radiologists....
info_outline
How Generative Vision Language AI is Transforming Radiology with Louis Blankemeier Cognita
Empowered Patient Podcast
Louis Blankemeier, CEO and Co-Founder of Cognita, describes the significant gap between the number of radiologists and the rising volume and types of medical imaging that need to be reviewed. The Cognita generative visual language model is an advancement over earlier radiology AI applications that were designed to flag single findings. This integrated approach emulates a radiologist by analyzing complex images and generating full draft radiology reports, demonstrating reduced time per case, increased detection of critical findings, and decreased cognitive burden on radiologists....
info_outline
Virtual Physical Therapy Matches In-Clinic Outcomes While Expanding Access and Convenience with Dr. Ashok Gupta Theranow TRANSCRIPT
Empowered Patient Podcast
Dr. Ashok Gupta, CEO and Founder of Theranow, highlights the growing demand for physical therapy and the challenges patients face in accessing care. The Theranow telehealth solution uses technologies such as computer vision and AI to enhance the effectiveness and efficiency of virtual care and to measure and document progress to support the clinician's work with the patient. Virtual physical therapy is demonstrating outcomes equal to in-person care and showing higher patient engagement and compliance, driven by the convenience of scheduling and remote monitoring tools. Ashok explains,...
info_outline
Virtual Physical Therapy Matches In-Clinic Outcomes While Expanding Access and Convenience with Dr. Ashok Gupta Theranow
Empowered Patient Podcast
Dr. Ashok Gupta, CEO and Founder of Theranow, highlights the growing demand for physical therapy and the challenges patients face in accessing care. The Theranow telehealth solution uses technologies such as computer vision and AI to enhance the effectiveness and efficiency of virtual care and to measure and document progress to support the clinician's work with the patient. Virtual physical therapy is demonstrating outcomes equal to in-person care and showing higher patient engagement and compliance, driven by the convenience of scheduling and remote monitoring tools. Ashok explains,...
info_outline
Enzyme Replacement Therapy for Sanfilippo Syndrome Type B with Dr. Javier Szwarcberg Spruce Biosciences TRANSCRIPT
Empowered Patient Podcast
Dr. Javier Szwarcberg, CEO of Spruce Biosciences, is developing drugs for rare diseases with a primary focus on Sanfilippo Syndrome Type B, a devastating genetic neurodegenerative disease affecting children. The source of this condition is a lack of an enzyme, which results in a buildup of a toxic substance in the brain. The company's drug is an enzyme replacement therapy administered directly to the brain to bypass the blood-brain barrier, and clinical trial data is showing a strong effect on the toxic substrate in the brain and a meaningful benefit on cognition. Javier...
info_outline
Enzyme Replacement Therapy for Sanfilippo Syndrome Type B with Dr. Javier Szwarcberg Spruce Biosciences
Empowered Patient Podcast
Dr. Javier Szwarcberg, CEO of Spruce Biosciences, is developing drugs for rare diseases with a primary focus on Sanfilippo Syndrome Type B, a devastating genetic neurodegenerative disease affecting children. The source of this condition is a lack of an enzyme, which results in a buildup of a toxic substance in the brain. The company's drug is an enzyme replacement therapy administered directly to the brain to bypass the blood-brain barrier, and clinical trial data is showing a strong effect on the toxic substrate in the brain and a meaningful benefit on cognition. Javier...
info_outline
AI in Complex Healthcare Revenue Cycle Management with Zach Shultz EnableComp TRANSCRIPT
Empowered Patient Podcast
Zach Shultz, Senior Director of Product Policy and Solutions at EnableComp, describes the challenges of revenue cycle management in healthcare with a focus on the strategic importance of full-time equivalent (FTE) allocation. Hospitals could improve their bottom line by outsourcing complex, low-reimbursement claims, such as those from the VA so that in-house staff can focus on higher-value commercial claims. Despite the emergence of AI as a significant factor in automating the review process, human intervention is irreplaceable for quality assurance, managing escalations, and resolving...
info_outline
AI in Complex Healthcare Revenue Cycle Management with Zach Shultz EnableComp
Empowered Patient Podcast
Zach Shultz, Senior Director of Product Policy and Solutions at EnableComp, describes the challenges of revenue cycle management in healthcare with a focus on the strategic importance of full-time equivalent (FTE) allocation. Hospitals could improve their bottom line by outsourcing complex, low-reimbursement claims, such as those from the VA so that in-house staff can focus on higher-value commercial claims. Despite the emergence of AI as a significant factor in automating the review process, human intervention is irreplaceable for quality assurance, managing escalations, and resolving...
info_outline
In-Home High-Acuity Care is Transforming Emergency Medicine with Lon Hecht Care2U TRANSCRIPT
Empowered Patient Podcast
Lon Hecht, CEO of Care2U, has designed an innovative model of providing in-home high-acuity care as an alternative to emergency room visits or hospitalizations. The process includes sending a clinician to the home within 2-4 hours, with extensive mobile medical equipment, and physician support via telehealth. Benefits include better patient recovery outcomes, significant cost savings for patients and payers, and prevention of costly hospital readmissions. Lon explains, "My company, Care2U, and I are bringing high acuity care into the home. So think of it as kind of a...
info_outline
In-Home High-Acuity Care is Transforming Emergency Medicine with Lon Hecht Care2U
Empowered Patient Podcast
Lon Hecht, CEO of Care2U, has designed an innovative model of providing in-home high-acuity care as an alternative to emergency room visits or hospitalizations. The process includes sending a clinician to the home within 2-4 hours, with extensive mobile medical equipment, and physician support via telehealth. Benefits include better patient recovery outcomes, significant cost savings for patients and payers, and prevention of costly hospital readmissions. Lon explains, "My company, Care2U, and I are bringing high acuity care into the home. So think of it as kind of a...
info_outlineLouis Blankemeier, CEO and Co-Founder of Cognita, describes the significant gap between the number of radiologists and the rising volume and types of medical imaging that need to be reviewed. The Cognita generative visual language model is an advancement over earlier radiology AI applications that were designed to flag single findings. This integrated approach emulates a radiologist by analyzing complex images and generating full draft radiology reports, demonstrating reduced time per case, increased detection of critical findings, and decreased cognitive burden on radiologists.
Louis explains, "Radiologists look at a number of different imaging types. So there are X-rays, and these are basically 2D images or 2D projections of the inside of the body. So you see all the organs superimposed on each other in a 2D image. And the radiologists have to take this 2D image and create almost a 3D representation in their head to understand what's going on in the body. They also read CT scans, which use X-ray radiation but take multiple images from different angles of the body. And then you basically reconstruct a 3D video that shows you what the inside of a body looks like. And then there are also MRI scans, which use magnetism to create a video of the inside of the body. And CT and MRI are 3D imaging modalities. So they're both kind of like videos. And you have an ultrasound, which uses sound waves, and you have a long tail of different imaging types. But radiologist spend most of their time looking at X-rays, CT scans, and MRI images."
"A vision language model is a model that has eyes, so it can actually look at images, and then the language part describes how we are generating text in the output. And we can actually add one more descriptor to vision language. We can add the term generative. So we're actually generating text in the output of our model. We're generating the radiology report. And this is in contrast to most models out there today that are discriminative. There are these classifier models that are saying, " Is there a disease present or not? And the output is binary. It's zero one. It's not a text report in the output."
#Cognita #AIinRadiology #GenerativeAI #VisionLanguageModels #RadiologyWorkflow #DiagnosticImaging #MedicalAI #HealthcareInnovation #RadiologistSupport #ClinicalDecisionSupport #PatientSafety #BurnoutReduction #FDA #BreakthroughDevice #DigitalHealth #HealthTech
